Alberto Estevez Selected Research

jorumycin

6/2006

Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Estevez Research Topics

Disease

5	Neoplasms (Cancer) 10/2021 - 06/2006
2	Asthma (Bronchial Asthma) 01/2021 - 12/2020
2	Macular Degeneration (Age-Related Maculopathy) 01/2020 - 12/2015
2	Infections 01/2017 - 07/2013
1	Cough 01/2021
1	Pain (Aches) 01/2021
1	Edema (Dropsy) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Necrosis 01/2020
1	Blindness (Hysterical Blindness) 01/2020
1	Macular Edema 01/2020
1	Leukemia 10/2018
1	Lymphoma (Lymphomas) 10/2018
1	Human Influenza (Influenza) 07/2013
1	Osteoporosis 09/2012

Drug/Important Bio-Agent (IBA)

2	Monoclonal AntibodiesIBA 01/2020 - 01/2017
1	Pharmaceutical PreparationsIBA 10/2021
1	GDC-0334IBA 01/2021
1	Transient Receptor Potential ChannelsIBA 01/2021
1	trypsin-like serine proteaseIBA 12/2020
1	Tryptases (Tryptase)IBA 12/2020
1	TIE-2 Receptor (Receptor, TIE 2)IBA 01/2020
1	Immunoglobulin M (IgM)IBA 01/2020
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 10/2018
1	ibrutinibIBA 10/2016
1	Agammaglobulinaemia Tyrosine KinaseIBA 10/2016
1	Serine Proteases (Serine Protease)IBA 12/2015
1	TrypsinIBA 12/2015
1	Oseltamivir (Tamiflu)FDA Link 07/2013
1	AntibodiesIBA 07/2013
1	Peptide Hormones (Polypeptide Hormones)IBA 09/2012
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 09/2012
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2006
1	3-epi-renieramycin GIBA 06/2006
1	1,2,3,4-tetrahydroisoquinolineIBA 06/2006
1	jorumycinIBA 06/2006
1	renieramycin GIBA 06/2006
1	3-epi-jorumycinIBA 06/2006

Therapy/Procedure

1	Therapeutics 01/2021